Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
34
Number of overlapping holdings
34.7%
% of WDNA's 99 holdings also in GNOM
82.9%
% of GNOM's 41 holdings also in WDNA
Overlap by Weight
Sector Drift (WDNA minus GNOM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in GNOM |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 2.1% | 2.4% | 2.1% |
|
VERTEX PHARMACEUTICALS INC | 2.4% | 2.0% | 2.0% |
|
AGILENT TECHNOLOGIES INC | 1.9% | 4.5% | 1.9% |
|
ALNYLAM PHARMACEUTICALS INC | 1.8% | 4.2% | 1.8% |
|
SAREPTA THERAPEUTICS INC | 1.8% | 4.0% | 1.8% |
Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to GNOM
 |
ASTRAZENECA PLC-SPONS ADR | 2.9% |
|
ARCHER-DANIELS-MIDLAND CO | 2.2% |
|
PFIZER INC | 2.1% |
|
ELI LILLY & CO | 2.0% |
|
CORTEVA INC | 2.0% |
|
MERCK & CO. INC. | 2.0% |
|
THERMO FISHER SCIENTIFIC INC | 1.9% |
|
REGENERON PHARMACEUTICALS | 1.9% |
|
BIOGEN IDEC INC | 1.9% |
|
DANAHER CORP | 1.8% |
WDNA Underweight Relative to GNOM
|
10X GENOMICS INC CLASS A | -4.7% |
|
CRISPR THERAPEUTICS AG | -3.4% |
|
INTELLIA THERAPEUTICS, INC. | -3.4% |
 |
GENSCRIPT BIOTECH CORPORATION | -3.4% |
 |
BIONTECH SE SPONSORED ADR | -3.3% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -3.2% |
|
BIO-TECHNE CORPORATION | -3.2% |
|
BEAM THERAPEUTICS, INC. | -3.1% |
|
ULTRAGENYX PHARMACEUTICAL IN | -3.1% |
|
PACIFIC BIOSCIENCES OF CALIF | -3.0% |